NOVOS
NOVOS is an Aging Diagnostics & Biomarkers company founded in 2020 and based in New York, United States. It has raised $3.1M in total funding, most recently a Pre-seed in 2021.
NOVOS (NOVOS Labs) is a New York-based public benefit corporation building a consumer longevity stack organized around the hallmarks of aging. Founded by CEO Chris Mirabile with co-founder Kris Verburgh, MD, it sells multi-ingredient longevity supplements alongside an at-home epigenetic test that reports biological age, pace of aging, organ-age, and telomere outputs. The company closed $3.15M in pre-seed financing led by Resolute Ventures in 2021, with participation from Arkitekt Ventures and others, and counts longevity scientists including George Church, Joao Pedro de Magalhaes, and Matt Kaeberlein among its advisors.
Bridges consumer longevity supplements and biological-age testing with an unusually science-forward, advisor-heavy positioning.
novoslabs.com ↗·Aging Diagnostics & Biomarkers·
United States·private 
